The Pro12Ala polymorphism in the PPARγ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus
Abstract Background The peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. Several studies have demonstrated a significant association between Pro12Ala polymorphism of the PPARγ2 gene and metabolic...
Main Authors: | Leila Saremi, Shirin Lotfipanah, Masumeh Mohammadi, Hassan Hosseinzadeh, Mina Fathi-Kazerooni, Behrooz Johari, Zohreh Saltanatpour |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s11658-019-0138-0 |
Similar Items
-
The use of CHS-131, a selective PPAR-gamma modulator to treat NAFLD/NASH
by: Joshi, Aditya
Published: (2020) -
Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population
by: Abdulbari Bener, et al.
Published: (2015-01-01) -
Study on distribution of Pro12Ala single nucleotide polymorphism of PPARγ2 gene in randomly sampled diabetic population from Guwahati city
by: Navaneeta Majumdar, et al.
Published: (2014-09-01) -
Crosstalk between PPARs and gut microbiota in NAFLD
by: Liwei Wu, et al.
Published: (2021-04-01) -
Assessment of the Pro12Ala Polymorphism in the PPAR-γ2 Gene among Type 2 Diabetes Patients in a Nigerian Population
by: Godwill Azeh Engwa, et al.
Published: (2018-04-01)